Device and system for monitoring and treating muscle tension-related medical conditions
AssigneeBiotrak Health, Inc.
InventorsEric Lee, Robert L. Bratzler, Erk Lillydahl, Adam Kirell
Life of this patent
Estimating the term…
Abstract
Mobile systems and devices can employ surface electromyography (sEMG) technology and other sensing technologies for measuring muscle tension and managing chronic pain conditions. These systems and devices can sense and quantify excessive muscle tension and can facilitate management of excessive muscle tension and chronic pain through cognitive behavioral therapy, pharmacologic intervention, or a combination of both.
Claims51
A system for detecting muscle tension, comprising:
- a wearable device having at least one sensor unit configured to generate at least one output indicative of a level of muscle tension, and circuitry for processing the output.
A system for detecting an indication, comprising:
- a wearable device having a sensor unit configured to detect one or more biological signals of the indication, the sensor unit further configured to generate an output indicative of the indication, and circuitry for processing the output.
The method of claim 41, wherein the pharmacologic agent is selected from the group consisting of Avonex (interferon beta-1a), Betaseron (interferon beta-1b), Copaxone (glatiramer acetate), Extavia (interferon beta-1b), Glatopa (glatiramer acetate), Plegridy (peginterferon beta-1a), Rebif (interferon beta-1a), Zinbryta (daclizumab), Aubagio (teriflunomide), Gilenya (fingolimod), Tecfidera (dimethyl fumarate), Lemtrada (alemtuzumab), Novantrone (mitoxantrone), Ocrevus (ocrelizumab), Tysabri (natalizumab), Paxil, Zoloft, Prozac, and other biologicals or small-molecule drugs for treating depression.
Dependencies are inferred from the claim text.